Cargando…

Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine

Among the gynecological cancers, ovarian cancer is the most lethal. Its therapeutic options include a combination of chemotherapy with platinum-based compounds and cytoreductive surgery. Most ovarian cancer patients exhibit an initial response to platinum-based therapy, however, platinum resistance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Chong, Song, Chaoying, Zhang, Jiali, Gao, Yisong, Qi, Yuying, Zhao, Zongyao, Yuan, Chengfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243319/ https://www.ncbi.nlm.nih.gov/pubmed/35782973 http://dx.doi.org/10.1016/j.gendis.2020.11.017

Ejemplares similares

Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance
por: Levin, May, et al.
Publicado: (2021)

Tumor evolution and chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

MSLN Correlates With Immune Infiltration and Chemoresistance as a Prognostic Biomarker in Ovarian Cancer
por: Li, Yike, et al.
Publicado: (2022)

An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4
por: Varier, Lavanya, et al.
Publicado: (2023)

Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020)

Adipocytes promote ovarian cancer chemoresistance
por: Yang, Jiang, et al.
Publicado: (2019)

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
por: Huang, He, et al.
Publicado: (2012)

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
por: Ricciardelli, Carmela, et al.
Publicado: (2013)

Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer
por: Matthews, Bayley G., et al.
Publicado: (2021)

Circular RNAs: new biomarkers of chemoresistance in cancer
por: Wang, Jiaqi, et al.
Publicado: (2021)

What biomarkers (if any) for precise medicine?
por: Strano, Sabrina, et al.
Publicado: (2015)

Biomarker Application for Precision Medicine in Stroke
por: Simpkins, Alexis N., et al.
Publicado: (2019)

A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance
por: Chen, Lu, et al.
Publicado: (2023)

Technicolour and precision electroweak data revisited
por: Ellis, Jonathan Richard, et al.
Publicado: (1995)

Molecular mechanisms of chemoresistance in gastric cancer
por: Shi, Wen-Jia, et al.
Publicado: (2016)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
por: Emmings, Edith, et al.
Publicado: (2019)

Chemoresistance and targeted therapies in ovarian and endometrial cancers
por: Brasseur, Kevin, et al.
Publicado: (2016)

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Dar, Sajad, et al.
Publicado: (2017)

Bevacizumab as adjunct to chemotherapy for chemoresistant ovarian cancer
por: Hamilton, Gerhard
Publicado: (2020)

Use of MRI, metabolomic, and genomic biomarkers to identify mechanisms of chemoresistance in glioma
por: Levenson, Cathy W., et al.
Publicado: (2019)

The role of DNA methylation in ovarian cancer chemoresistance: A narrative review
por: Song, Kaiyang, et al.
Publicado: (2023)

Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms
por: Wang, Zhijun, et al.
Publicado: (2016)

Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis
por: Li, Zhang, et al.
Publicado: (2021)

Cross-validation of genes potentially associated with neoadjuvant chemotherapy and platinum-based chemoresistance in epithelial ovarian carcinoma
por: Zhang, Kai, et al.
Publicado: (2020)

RNA Biomarkers: Frontier of Precision Medicine for Cancer
por: Xi, Xiaochen, et al.
Publicado: (2017)

Chemoresistance in human ovarian cancer: the role of apoptotic regulators
por: Fraser, Michael, et al.
Publicado: (2003)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2017)

Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
por: Gu, Fei, et al.
Publicado: (2019)

Chemoresistance is mediated by ovarian cancer leader cells in vitro
por: Karimnia, Nazanin, et al.
Publicado: (2021)

Targeting BMI1 mitigates chemoresistance in ovarian cancer
por: Dey, Anindya, et al.
Publicado: (2022)

The molecular mechanisms of chemoresistance in cancers
por: Zheng, Hua-Chuan
Publicado: (2017)

Early Mechanisms of Chemoresistance in Retinoblastoma
por: Zhang, Michelle G., et al.
Publicado: (2022)

SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1
por: Gao, Wujiang, et al.
Publicado: (2022)

Redox-Mediated Mechanism of Chemoresistance in Cancer Cells
por: Kim, Eun-Kyung, et al.
Publicado: (2019)

Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis
por: Li, Yuan, et al.
Publicado: (2023)

Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Disease Biomarkers for Precision Medicine: Challenges and Future Opportunities
por: Wang, Edwin, et al.
Publicado: (2017)

Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine
por: Lukiw, Walter J., et al.
Publicado: (2020)

Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
por: Beger, Richard D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h8kguv7fn49lj8581pgq34if9n